Video
Dr. Lalani on Neutrophil-Lymphocyte Ratio in RCC
Author(s):
Aly-Khan Lalani, MD, genitourinary oncology fellow, Dana-Farber Cancer Institute, discusses neutrophil-lymphocyte ratio in renal cell carcinoma.
Aly-Khan Lalani, MD, genitourinary oncology fellow, Dana-Farber Cancer Institute, discusses neutrophil-lymphocyte ratio in renal cell carcinoma (RCC).
The ratio of neutrophil to lymphocytes was compared in a study of patients with RCC treated with immunotherapy.
Neutrophils reflect the inflammatory cascade in patients with cancer, says Lalani, and lymphocytes are an important antitumor agent.
Related Videos
Related Content
